TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | -1 | 1 | 18 | -9 | -10 | 19 | 3 |
S | %wins | 50 | 25 | 0 | 50 | 50 | 0 | 29 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/19/16 16:23 | 7/15/16 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivaldi Coelho Rogerio | PA | O | Chief Co | S.d | -371 | 53.03 | 28 | -7 | -27 | 19 | D | -16 | 79 | 44 | -6 | 16 | -3 | -1 | 4 | 2 | 13 | 6 | 3 | ||
4/22/16 16:07 | 4/20/16 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivaldi Coelho Rogerio | PA | O | Chief Co | S.dm | -280 | 40.02 | 10 | -7 | -27 | 19 | D | -39 | -27 | 30 | 24 | 26 | 20 | 8 | -5 | -11 | 25 | 34 | 27 | ||
10/14/15 19:32 | 10/13/15 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivaldi Coelho Rogerio | PA | O | Chief Co | S.d | -1,156 | 48.15 | 33 | -24 | -56 | 19 | D | -37 | -19 | 9 | 9 | 9 | 1 | 3 | 7 | 19 | -42 | -33 | 12 | ||
10/9/15 19:21 | 10/7/15 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vivaldi Coelho Rogerio | PA | O | Chief Co | S.d | -2,003 | 48.85 | 33 | -41 | -88 | 5 | D | -34 | -22 | 7 | 1 | 22 | -11 | -4 | 7 | 14 | -32 | -36 | 25 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |